Philly’s year in biopharma: a look back at 2024
Two Philadelphia biotech companies scored approval in 2024 for first-of-their-kind gene therapy treatments for solid cancer tumors and melanoma. Those achievements by Iovance Biotherapeutics and Adaptimmune, companies in South Philadelphia’s Navy Yard, …